Patent · US Active

Composition of ferric maltol for oral administration

US12396999B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2022
Grant dateAug 26, 2025
Priority date
Expiry dateJul 27, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/4866
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to an improved composition of ferric maltol or ferric trimaltol for the treatment of iron deficiency, wherein the composition comprises the active ferric maltol or ferric trimaltol lower than 60% of the total composition weight. The compositions further can be a capsule or tablet or any other pharmaceutical solid dosage form, preferably a capsule in a hard gelatin in a size of 0 or 1, for oral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.